Showing 2131-2140 of 2657 results for "".
- Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Programshttps://modernod.com/news/glaukos-announces-positive-clinical-updates-for-several-corneal-health-pipeline-programs/2481343/Glaukos announced positive clinical updates for several of its corneal health pipeline programs, including the commencement of subject enrollment in a second phase 3 confirmatory trial for Epioxa (Epi-on), and initial results from the company’s phase 2a clinical trial for GLK-301
- Rayner Launches ‘Peer2Peer: The Podcast’ for Clinical Educationhttps://modernod.com/news/rayner-launches-peer2peer-the-podcast-for-clinical-education/2481342/Rayner announced the launch of the latest addition to their Peer2Peer clinical education platform, "Peer2Peer: The Podcast." Topics included in the podcase include the do's and don’ts of implanting toric IOLs; marketing your clinic online; popular
- Neurotech Pharmaceuticals Appoints Scott Hunter as Chief Commercial Officerhttps://modernod.com/news/neurotech-pharmaceuticals-appoints-scott-hunter-as-chief-commercial-officer/2481341/Neurotech Pharmaceuticals announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two decades of eye care experience across both rare disease and specialty markets. “Scott’s appointment as the company&rsquo
- Alcon Champions Access to Eye Care with Opening of Children’s Vision Center in Fort Worth, Texashttps://modernod.com/news/alcon-champions-access-to-eye-care-with-opening-of-childrens-vision-center-in-fort-worth-texas/2481337/Alcon announced the grand opening of the Alcon Children’s Vision Center. Located at 8376 Mojave Trail in Fort Worth, Texas, the center is a first-of-its-kind partnership between the Alcon Foundation and the Fort Worth Independent School District (FWISD). The center offers comprehensive
- Alimera Sciences Appoints Industry Veteran Russell L. Skibsted as Chief Financial Officerhttps://modernod.com/news/alimera-sciences-appoints-industry-veteran-russell-l-skibsted-as-chief-financial-officer/2481331/Alimera Sciences announced the appointment of Russell L. Skibsted as Senior Vice President and Chief Financial Officer (CFO), effective January 9, 2023. “We are extremely excited to have someone of Russell’s caliber join us here at Alimera,” Rick Eiswirth, P
- Alcon Introduces Reusable Toric Lens with Launch of TOTAL30 for Astigmatismhttps://modernod.com/news/alcon-introduces-reusable-toric-lens-with-launch-of-total30-for-astigmatism/2481324/Alcon announced plans to launch TOTAL30 for Astigmatism, which the company calls the first-and-only reusable contact lens with water gradient material for astigmatic contact lens wearers. Using Alcon’s proprietary water gradient material, first introduced with DAILIES TOTAL1&
- Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directorshttps://modernod.com/news/iveric-bio-announces-the-addition-of-pravin-u-dugel-md-to-its-board-of-directors/2481317/Iveric bio announced the election of Pravin U. Dugel, MD, President of Iveric Bio, to its Board of Directors, effective as of January 1, 2023. Dr. Dugel has been instrumental in helping to shape the company’s business strategy and in overseeing the development and regulatory submission
- AAO: Prior Authorization Reform Effort Gets Boost from CMShttps://modernod.com/news/aao-prior-authorization-reform-effort-gets-boost-from-cms/2481310/The Centers for Medicare & Medicaid Services (CMS) released a proposed rule that "closely aligns" with the Improving Seniors’ Timely Access to Care Act (S. 3018/H.R. 3173), a bill the American Academy of Ophthalmology helped craft, according to an AAO news release. If ado
- New Genetic Mutation Behind Childhood Glaucoma Identifiedhttps://modernod.com/news/new-genetic-mutation-behind-childhood-glaucoma-identified/2481303/An international team led by Harvard Medical School scientists at Mass Eye and Ear and Boston Children’s Hospital has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, according to a Harvard Medical School research
- Staar Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEOhttps://modernod.com/news/staar-surgical-ceo-caren-mason-to-retire-tom-frinzi-appointed-new-ceo/2481302/Staar Surgical announced that President and Chief Executive Officer Caren Mason will be retiring December 31, 2022, after serving in that postion for 7 years. Staar's Board of Directors has appointed ophthalmic industry executive Thomas G. Frinzi, current Board Chair of Staar,